Table 4 Medication use six months prior to baseline by age at enrolment
Age group, years | ||||||||
|---|---|---|---|---|---|---|---|---|
5–10 (N = 66) | 11–15 (N = 36) | 16–20 (N = 17) | 21–30 (N = 22) | 31–40 (N = 14) | 41–50 (N = 15) | 51–60 (N = 8) | ≥ 61 (N = 8) | |
Total medication count per patient | ||||||||
n | 66 | 36 | 17 | 22 | 14 | 15 | 8 | 8 |
Mean (SD) | 0.5 (1.42) | 0.3 (0.73) | 0.6 (0.93) | 0.5 (1.41) | 0.2 (0.43) | 1.0 (1.60) | 1.3 (1.28) | 1.3 (2.05) |
Median | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | 0.5 |
Min, Max | 0, 8 | 0, 3 | 0, 3 | 0, 6 | 0, 1 | 0, 5 | 0, 3 | 0, 6 |
Total medication frequency, n (%) | ||||||||
0 | 52 (78.8%) | 31 (86.1%) | 10 (58.8%) | 17 (77.3%) | 11 (78.6%) | 9 (60.0%) | 3 (37.5%) | 4 (50.0%) |
1 | 5 (7.6%) | 3 (8.3%) | 4 (23.5%) | 3 (13.6%) | 3 (21.4%) | 2 (13.3%) | 2 (25.0%) | 2 (25.0%) |
2 | 5 (7.6%) | 0 | 2 (11.8%) | 0 | 0 | 2 (13.3%) | 1 (12.5%) | 1 (12.5%) |
3 | 1 (1.5%) | 2 (5.6%) | 1 (5.9%) | 1 (4.5%) | 0 | 0 | 2 (25.0%) | 0 |
≥ 4 | 3 (4.5%) | 0 | 0 | 1 (4.5%) | 0 | 2 (13.3%) | 0 | 1 (12.5%) |
ATC Level 1 Term, n (%) | ||||||||
Alimentary tract and metabolism | 5 (7.6%) | 1 (2.8%) | 0 | 1 (4.5%) | 0 | 2 (13.3%) | 1 (12.5%) | 1 (12.5%) |
Antiinfectives for systemic use | 6 (9.1%) | 1 (2.8%) | 3 (17.6%) | 1 (4.5%) | 0 | 0 | 0 | 0 |
Blood and blood forming organs | 0 | 1 (2.8%) | 2 (11.8%) | 0 | 2 (14.3%) | 0 | 0 | 0 |
Cardiovascular system | 0 | 0 | 0 | 0 | 0 | 1 (6.7%) | 1 (12.5%) | 2 (25.0%) |
Dermatologicals | 2 (3.0%) | 0 | 0 | 0 | 0 | 1 (6.7%) | 0 | 1 (12.5%) |
Genito-urinary system and sex hormones | 0 | 0 | 1 (5.9%) | 0 | 0 | 2 (13.3%) | 1 (12.5%) | 0 |
Musculo-skeletal system | 0 | 1 (2.8%) | 1 (5.9%) | 0 | 0 | 3 (20.0%) | 2 (25.0%) | 1 (12.5%) |
Nervous system | 0 | 2 (5.6%) | 2 (11.8%) | 3 (13.6%) | 0 | 2 (13.3%) | 2 (25.0%) | 1 (12.5%) |
Respiratory system | 5 (7.6%) | 3 (8.3%) | 0 | 1 (4.5%) | 1 (7.1%) | 0 | 1 (12.5%) | 0 |
Sensory organs | 2 (3.0%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 (12.5%) |
Systemic hormonal preparations (excluding sex hormones and insulins) | 2 (3.0%) | 0 | 0 | 0 | 0 | 1 (6.7%) | 0 | 0 |